‘I just want to watch my daughter grow up’: Mother’s heartbreaking plea for breast cancer wonder drug Enhurtu being denied to women on the NHS, as new data shows it boosts survival by more than a third

The latest trial results found Enhertu slashed the chances of terminal breast cancer growing or spreading by 38 per cent compared to standard chemotherapy.The latest trial results found Enhertu slashed the chances of terminal breast cancer growing or spreading by 38 per cent compared to standard chemotherapy.Read MoreHealth News | Mail Online